Status:
COMPLETED
A Multidomain Approach to Preventing Dementia in African Americans: Cognitive Prescriptions
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Cognitive Change
Health Behavior
Eligibility:
All Genders
50-65 years
Phase:
NA
Brief Summary
The goal of this R21 study is to explore the feasibility and preliminary efficacy of individualized cognitive prescriptions (CogRxs) in improving engagement in healthy behaviors and other outcomes in ...
Detailed Description
A pre-post experimental design will be used, in which 150 AA participants aged 50-65 will complete a baseline assessment of cognitive testing and data-driven assessment of deficiencies across five Cog...
Eligibility Criteria
Inclusion
- Inclusions:
- Must be African American
- Must be age 50 to 65
- Must have a working cell phone with unlimited texting
- Must be ambulatory
- Exclusions:
- No neurological (including dementia diagnosis) or severe psychiatric (e.g., schizophrenia or bipolar disorder) disorders
- No insomnia
- Telephone Interview for Cognitive Status (TICS) score ≤20
Exclusion
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03864536
Start Date
January 1 2020
End Date
January 30 2022
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Holly Mears Building/Center for Research on Applied Gerontology
Birmingham, Alabama, United States, 35294